Key issues and strategies in the construction of biobank_West China Medical Journal

Authors：

XU Yan , FAN Ping ,  HU Xun

Biobank, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P. R. China;

Corresponding author：

HU Xun, Email: hxxhu99@163.com

Keywords：

Biobank; Construction; Key issue; Strategy

DOI：

10.7507/1002-0179.201803211

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Biobank is an important platform for translational medicine, precision medicine and drug development. In the past 10 years, although the construction of biobank in China has made great progress, it still faces many challenges. This article analyzes the key issues and also puts forward specific suggestions in the management of biobank from the aspects of ethics issues, quality control of biospecimens, information management, sample and data sharing, so as to provide reference for the construction and development of a high standard biobank.

Citation： XU Yan, FAN Ping, HU Xun. Key issues and strategies in the construction of biobank. West China Medical Journal, 2018, 33(6): 651-654. doi: 10.7507/1002-0179.201803211 Copy

1.	贺晶, 白杨, 池慧, 等. 我国生物样本库建设管理中存在的问题及规范化管理策略. 医学信息学杂志, 2017, 38(1): 53-58.
2.	钱开宇, 朱源, 曹馨月, 等. 加强伦理委员会建设, 促进生物样本库发展. 转化医学杂志, 2018, 7(1): 14-16, 41.
3.	Sun HY, Sun R, Hao M, et al. Effect of duration of ex vivo ischemia time and storage period on RNA quality in biobanked human renal cell carcinoma tissue. Ann Surg Oncol, 2016, 23(1): 297-304.
4.	Pieragostino D, Petrucci F, Del Boccio PA, et al. Pre-analytical factors in clinical proteomics investigations: impact of ex vivo protein modifications for multiple sclerosis biomarker discovery. J Proteomics, 2010, 73(3, SI): 579-592.
5.	Plebani M, Sciacovelli L, Aita A, et al. Harmonization of pre-analytical quality indicators. Biochem Med (Zagreb), 2014, 24(1): 105-113.
6.	Imbeaud S, Graudens E, Boulanger V, et al. Towards standardization of RNA quality assessment using user-independent classifiers of microcapillary electrophoresis traces. Nucleic Acids Res, 2005, 33(6): e56.
7.	Caixeiro NJ, Lai K, Lee CS. Quality assessment and preservation of RNA from biobank tissue specimens: a systematic review. J Clin Pathol, 2016, 69(3): 260-265.
8.	Faltas BM. Designing and managing modern biobanks. Genet Eng Biotechn N, 2013, 33(16): 38, 40.
9.	del Campo M, Mollenhauer B, Bertolotto A, et al. Recommendations to standardize preanalytical confounding factors in Alzheimer’s and Parkinson’s disease cerebrospinal fluid biomarkers: an update. Biomark Med, 2012, 6(4): 419-430.
10.	Nanni U, Betsou F, Riondino S, et al. SPRECware: software tools for Standard PREanalytical Code (SPREC) labeling - effective exchange and search of stored biospecimens. Int J Biol Markers, 2012, 27(3): e272-e279.
11.	翟培军, 李军燕, 胡冬梅, 等. 生物样本库国际认可和标准化发展与前景. 中华临床实验室管理电子杂志, 2017, 5(1): 6-8.
12.	周一峰, 闵伟勇, 张小燕, 等. 中国生物样本库质量达标检查结果分析. 实用器官移植电子杂志, 2017, 5(6): 444-447.
13.	Somiari SB, Somiari RI. The future of biobanking: a conceptual look at how biobanks can respond to the growing human biospecimen needs of researchers. Adv Exp Med Biol, 2015, 864: 11-27.
14.	刘世建, 傅启华, 王伟, 等. 临床生物样本库发展的机遇与挑战. 第二军医大学学报, 2017, 38(3): 265-269.

1. 贺晶, 白杨, 池慧, 等. 我国生物样本库建设管理中存在的问题及规范化管理策略. 医学信息学杂志, 2017, 38(1): 53-58.
2. 钱开宇, 朱源, 曹馨月, 等. 加强伦理委员会建设, 促进生物样本库发展. 转化医学杂志, 2018, 7(1): 14-16, 41.
3. Sun HY, Sun R, Hao M, et al. Effect of duration of ex vivo ischemia time and storage period on RNA quality in biobanked human renal cell carcinoma tissue. Ann Surg Oncol, 2016, 23(1): 297-304.
4. Pieragostino D, Petrucci F, Del Boccio PA, et al. Pre-analytical factors in clinical proteomics investigations: impact of ex vivo protein modifications for multiple sclerosis biomarker discovery. J Proteomics, 2010, 73(3, SI): 579-592.
5. Plebani M, Sciacovelli L, Aita A, et al. Harmonization of pre-analytical quality indicators. Biochem Med (Zagreb), 2014, 24(1): 105-113.
6. Imbeaud S, Graudens E, Boulanger V, et al. Towards standardization of RNA quality assessment using user-independent classifiers of microcapillary electrophoresis traces. Nucleic Acids Res, 2005, 33(6): e56.
7. Caixeiro NJ, Lai K, Lee CS. Quality assessment and preservation of RNA from biobank tissue specimens: a systematic review. J Clin Pathol, 2016, 69(3): 260-265.
8. Faltas BM. Designing and managing modern biobanks. Genet Eng Biotechn N, 2013, 33(16): 38, 40.
9. del Campo M, Mollenhauer B, Bertolotto A, et al. Recommendations to standardize preanalytical confounding factors in Alzheimer’s and Parkinson’s disease cerebrospinal fluid biomarkers: an update. Biomark Med, 2012, 6(4): 419-430.
10. Nanni U, Betsou F, Riondino S, et al. SPRECware: software tools for Standard PREanalytical Code (SPREC) labeling - effective exchange and search of stored biospecimens. Int J Biol Markers, 2012, 27(3): e272-e279.
11. 翟培军, 李军燕, 胡冬梅, 等. 生物样本库国际认可和标准化发展与前景. 中华临床实验室管理电子杂志, 2017, 5(1): 6-8.
12. 周一峰, 闵伟勇, 张小燕, 等. 中国生物样本库质量达标检查结果分析. 实用器官移植电子杂志, 2017, 5(6): 444-447.
13. Somiari SB, Somiari RI. The future of biobanking: a conceptual look at how biobanks can respond to the growing human biospecimen needs of researchers. Adv Exp Med Biol, 2015, 864: 11-27.
14. 刘世建, 傅启华, 王伟, 等. 临床生物样本库发展的机遇与挑战. 第二军医大学学报, 2017, 38(3): 265-269.

West China Medical Journal

Key issues and strategies in the construction of biobank

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content